The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
Kent Holtorf, MD - LDN should be considered a first-line therapy for CFS/FM (2019 Conference) (LDN, low dose naltrexone)
Amy Lamb, Pharm - A Pharmacist's Perspective on Comprehensive Immune Health Consultations and Applications of LDN (2019 Conference) (LDN, low dose naltrexone)
Dr John Kim, LDN Radio Show 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Linda Elsegood: Today I'm joined by Dr. John Kim from Georgia Integrative Medicine Clinic in the US. Thank you for joining us today.
Annie (2) - England: Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Linda Elsegood: I'd like to introduce Annie from England who has multiple sclerosis?
Good morning, Annie. Could you tell us when you were diagnosed with MS?
Zora - Trinidad: Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Zora from Trinidad shares her Multiple Sclerosis (MS) and Low Dose Naltrexone (LDN) story on the LDN Radio Show with Linda Elsegood.
Wendy - England: Multiple Sclerosis (MS) (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Wendy was diagnosed with Multiple Sclerosis in 2000 at the age of 60. She first heard about Low Dose Naltrexone on an online forum and her doctor refused to prescribe it so she got a prescription privately.